Osteoporosis Management in Patients with Post-Polio Myelitis
Assessment and Treatment Considerations
- Advanced age (82 years) combined with post-polio myelitis creates a complex clinical picture requiring careful risk-benefit assessment, according to the American Geriatrics Society 1
- Bone health assessment should include bone mineral density (BMD) via DEXA scan, as recommended by the European League Against Rheumatism 2
- Fracture risk assessment using FRAX calculation is essential, although the strength of evidence is not specified 3
- Evaluation of renal function before initiating bisphosphonate therapy is crucial, with the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines suggesting not prescribing bisphosphonate treatment in people with GFR <30 ml/min/1.73 m² without strong clinical rationale 4
- Renal function should be monitored in patients on bisphosphonates, as suggested by the National Comprehensive Cancer Network 5
- Calcium (1,000–1,500 mg/day) and vitamin D (800 IU/day) supplementation should be considered as baseline therapy, according to the European League Against Rheumatism 2
- Physical activity designed to improve spine mechanics should be encouraged as tolerated, with moderate evidence supporting its benefits 6
Monitoring and Treatment Duration
- Regular monitoring of bone health is essential, with DEXA scan repeated after 1-2 years when rapid bone loss is expected, as recommended by the European Association for the Study of the Liver 6
- Lateral X-rays of spine for diagnosing vertebral fractures should be performed regularly, with the frequency depending on individual patient risk factors 6